News

Seattle, WA and Miamisburg, OH – October 3, 2024 – RevealDx and Riverain Technologies, leaders in the detection and characterization of lung nodules, announced the integration of their products, as well as distribution by Riverain in Canada. Both companies will be exhibiting at the CHEST Meeting beginning October 7, 2024. The RevealDX technology characterizes nodules RevealDx and Riverain Technologies Partner to Improve Lung Cancer Detection with mSI Malignancy Scoring

[ MORE ]

RevealDx competed against 38 companies and received the award for the best poster at the Life Science Innovation Northwest Conference in Seattle in April 2023!  Life Science Innovation Northwest is part of the Life Science Washington Industry Organization.

[ MORE ]

Sirona leads a set of clinically-validated capabilities that amplifies the efficiency and precision of lung nodule assessment, improving diagnostic quality for the leading cause of cancer-related death in the United States. SAN FRANCISCO, Nov. 17, 2022 /PRNewswire/ — Sirona Medical, the leader in cloud-native radiology workflow software, today announced a comprehensive distribution and collaboration partnership with RevealDX and the integration of Sirona Medical partners with RevealDx to transform lung cancer screening with a comprehensive suite of reimbursed AI tools

[ MORE ]